The European Commission approved Opdivo plus Yervoy for first-line treatment of advanced liver cancer, citing significant ...

Bristol Myers Squibb has won the European Commission's expanded approval of its Opdivo plus Yervoy cancer-drug combination for early use in certain patients with liver cancer. Bristol Myers on Friday ...

An interval of fewer than 30 days between the last immunotherapy dose and the liver transplant increases the rejection risk ...

Researchers at Georgetown University have developed a new drug called CTPI-2, which targets a key gene known as Slc25a1. This ...

Histotripsy is an FDA-approved technology that offers liver cancer patients a non-invasive, painless, and highly effective treatment option ...

Metabolic cell death represents a rapidly evolving and intricate field within cancer research. Recent studies have elucidated ...

ASHLEY Robinson blamed his stomach issues on wedding stress – just weeks before discovering he had stage four bowel cancer.

Hepatocellular carcinoma (HCC) represents about 80 to 90% of cases of primary liver cancer. On a global level, 905,700 new ...

Discover the distinctive symptoms of liver pain, common underlying conditions, and effective treatment options to protect ...

Investigators have found that the gene Asah1 plays a crucial protective role in preventing the progression of nonalcoholic ...

Hepatocellular carcinoma (HCC) represents about 80 to 90% of cases of primary liver cancer. On a global level, 905,700 new cases and 830,200 deaths were registered in 2020 according to the World ...